BBT Biotech GmbH is your professional and reliable partner in the development, manufacturing and international sales of biopharmaceuticals. BBT Biotech, We are located in Baesweiler near Aachen, Germany, is specialized in the development, manufacturing and international sales of active pharmaceutical ingredients of biological origin. We focus on our two main competences in up- and downstream processing: Fermentation and protein purification. We offer Our key technologies include sophisticated manufacturing systems of a wide range of viable bacteria and yeasts as well as advanced protein purification and separation techniques (especially hormones and thrombolytic drugs) and special protein purification and separation methods (hormones, thrombolytic drugs) including the according in-house R&D and RA competences – all developed in-house. Furthermore we maintain a high-class quality control unit which has the ability to perform an extensive range of microbiological, biochemical, and chemical tests and analyses. Thus we are able to additionally offer laboratory services to our customers.
View Top Employees from BBT Biotech GmbHWebsite | http://www.bbt-biotech.de |
Revenue | $3 million |
Employees | 20 (19 on RocketReach) |
Address | 28 Arnold-sommerfeld-ring, Baesweiler, Nordrhein-Westfalen 52499, DE |
Phone | +49 2401 933100 |
Technologies |
HTML,
PHP,
Google Analytics
+2 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular BBT Biotech GmbH employee's phone or email?
The BBT Biotech GmbH annual revenue was $3 million in 2024.
Dirk Thoma is the COO of BBT Biotech GmbH.
19 people are employed at BBT Biotech GmbH.
BBT Biotech GmbH is based in Baesweiler, Nordrhein-Westfalen.
The NAICS codes for BBT Biotech GmbH are [32541, 325, 32, 3254].
The SIC codes for BBT Biotech GmbH are [28, 283].